<!DOCTYPE html>

<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Next-Gen Patient Avatar & AI Predictive Models</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <style>
        body {
            background: linear-gradient(145deg, #0f172a, #1e293b);
            color: #e2e8f0;
        }
        .glass {
            background: rgba(255, 255, 255, 0.05);
            backdrop-filter: blur(10px);
            border: 1px solid rgba(255, 255, 255, 0.1);
        }
        .tech-border {
            border-image: linear-gradient(90deg, #06b6d4, #8b5cf6) 1;
            border-width: 2px;
            border-style: solid;
        }
    </style>
</head>

<body class="font-sans leading-normal tracking-normal">

    <!-- Header -->
    <header class="bg-gradient-to-r from-cyan-700 to-purple-800 text-white shadow-lg">
        <nav class="container mx-auto px-6 py-4 flex justify-between items-center">
            <img src="images/logo-white.png" alt="aiPTO Logo" class="h-10">
            <ul class="flex">
                <li class="mx-3"><a href="#" class="hover:text-cyan-200">Home</a></li>
                <li class="mx-3"><a href="#about" class="hover:text-cyan-200">About</a></li>
                <li class="mx-3"><a href="#news" class="hover:text-cyan-200">News</a></li>
                <li class="mx-3"><a href="#contact" class="hover:text-cyan-200">Contact</a></li>
            </ul>
        </nav>
    </header>

    <!-- Hero Section -->
    <section class="text-center py-20">
        <div class="container mx-auto">
            <h2 class="text-5xl font-bold text-white">Revolutionize Brain Cancer Therapy</h2>
            <p class="mt-6 text-xl text-blue-200 max-w-2xl mx-auto">Integrating the best biological model and the best AI model creates personalized avatars and next-generation effective therapeutics</p>
        </div>
    </section>


<!-- About Section -->
<section id="about" class="py-20">
  <div class="container mx-auto px-6">
    <div class="glass p-8 rounded-lg shadow-xl flex flex-col md:flex-row gap-8 items-stretch">
      
      <!-- Left: Text Content -->
      <div class="flex-1 flex flex-col justify-between">
        <div>
          <h3 class="text-3xl font-bold mb-6 text-cyan-300">About</h3>

		  
		  <p class="text-lg text-blue-100 mb-6">
            A spinoff from the German Cancer Research Center (DKFZ), aiPTO harnesses the disruptive Individualized Patient Tumor Organoid (IPTO) technology which replicates tumor microenvironments at the molecular level and is predictive of clinical outcomes. It can be applied to a wide range of tumors of the central nervous system, from aggressive brain tumors such as glioblastomas to brain metastases.
          </p>

          <p class="text-lg text-blue-100 mb-6">
            aiPTO's proprietary generative AI technology with multiple task-specific AI agents is trained on the unique single cell sequencing data generated from IPTO. The AI agents are shown to be able to predict drug response on the single cell level, predict mechanism of action, and anticipate drug resistance and counter-resistance strategy. 
          </p>

          <p class="text-lg text-blue-100">
            By integrating the best biological model and the best AI model, aiPTO creates a powerful platform that tailors brain cancer therapy to the unique biology of each patient. This synergy redefines personalized medicine by improving drug efficacy, predicting resistance before it emerges, and reducing the time and cost of clinical development.
          </p>
        </div>
      </div>

      <!-- Right: IPTO Image + Caption -->
      <div class="flex-1 flex flex-col items-center justify-between">
        <img src="images/IPTO.jpg" alt="Patient Avatar Histology" class="rounded-xl shadow-2xl border-4 border-cyan-500 w-full h-full max-h-[450px] object-contain">
        <p class="text-sm text-blue-400 mt-4 text-center">
          Microphotography of an IPTO: the brain organoid grown from pluripotent stem cells is shown in green, the cells of the mini-tumor are stained red. Source: Liu/DKFZ.
        </p>
      </div>
    </div>
  </div>
</section>



    <!-- News Section -->
    <section id="news" class="py-20">
        <div class="container mx-auto px-6">
            <h3 class="text-3xl font-bold mb-6 text-cyan-300">News</h3>

            <div class="glass p-6 rounded-lg">
                    <h4 class="text-xl font-semibold text-white">Breakthrough Brain Cancer Avatar Model Published</h4>
                    <p class="text-blue-200">February 2025 - aiPTO celebrates the publication of pioneering research by scientific co-founder Prof. Haikun Liu, presenting the first brain cancer avatar model capable of predicting patient responses. This patient-derived organoid platform, integrated with aiPTO's generative AI, is transforming brain cancer precision medicine and drug development. <a href="https://www.linkedin.com/posts/dkfz-de_brain-tumor-organoid-activity-7295368974081445889-6A_B?utm_source=share&utm_medium=member_desktop&rcm=ACoAAANapYsBaxKA9hpf53ivGUTGtIr2C9QuHw8" class="text-cyan-400 underline" target="_blank">View LinkedIn post</a> &nbsp;|&nbsp; <a href="https://www.dkfz.de/en/news/press-releases/detail/new-perspectives-for-personalized-therapy-of-brain-tumors" class="text-cyan-400 underline" target="_blank">Read perspectives from DKFZ</a></p>
                </div>
                
                
                <div class="glass p-6 rounded-lg">
                    <h4 class="text-xl font-semibold text-white">aiPTO Spin-Off Announced by DKFZ</h4>
                    <p class="text-blue-200">December 2024 - DKFZ officially announces the spin-off of aiPTO, a next-generation techbio startup leveraging AI and organoid technology to revolutionize brain cancer therapy. <a href="https://www.linkedin.com/posts/dkfz-innovation_innovation-cancerresearch-braincancer-activity-7274709937778241537-JtsR?utm_source=share&utm_medium=member_desktop&rcm=ACoAAANapYsBaxKA9hpf53ivGUTGtIr2C9QuHw8" class="text-cyan-400 underline" target="_blank">View LinkedIn post</a></p>
                </div>
            </div>
        </div>
    </section>


<!-- Contact Section -->
<section id="contact" class="py-20">
  <div class="container mx-auto px-6">
    <h3 class="text-3xl font-bold mb-6 text-cyan-300">Contact</h3>
    <div class="glass w-full p-6 rounded-lg text-center">
      <p class="text-blue-100 text-lg mb-6">
        Send us an email at <a href="mailto:contact@aiptobio.com" class="text-cyan-400 underline">contact@aiptobio.com</a>
      </p>
    </div>
  </div>
</section>


    <!-- Footer -->
    <footer class="bg-gray-900 text-blue-300 text-center py-4">
        <p>Â© 2025 aiPTO. Revolutionize Brain Cancer Therapy.</p>
    </footer>

</body>
</html>
